Relative Strength Chart Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 230.71 USD | -0.77% |
|
+2.80% | +15.59% |
| Jul. 29 | Align Technology to add directors, launch review after deal with Elliott | RE |
| Jul. 20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Other Biotechnology & Medical Research | -0.84% | +2.80% | +15.59% | +37.32% | -43.93% | 11.2B |  | | |
- Stock Market
- Stocks
- CRL Stock
- Charts Charles River Laboratories International, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
